US Court Orders FDA to Reconsider E-Cigarette Sales Applications

Aug.25.2022
US Court Orders FDA to Reconsider E-Cigarette Sales Applications
US court orders FDA to reconsider rejection of six companies' e-cigarette applications, causing conflict with Washington, DC.

The United States federal appeals court has ruled that the Food and Drug Administration (FDA) must reconsider its decision to deny six companies permission to sell e-cigarette products. The ruling has caused a conflict between the court and Washington, D.C. The FDA has declined to comment on the decision.


Attorney Jerad Najvar of the Najvar law firm, representing e-cigarette liquid manufacturers Diamond Vapor, Union Street Brands, Vapor Unlimited LLC, and Johnny Copper LLC, stated that the FDA's belief that it can simply dismiss marketing plan review reports is incorrect. He explained that the agency mistakenly believes that his clients' liquid products have the same youth appeal as pre-filled liquid cartridges. The lawyer for Pop Vapor Co, the remaining company, did not immediately respond.


Electronic cigarettes deliver nicotine through the vaporization of liquid rather than the combustion of tobacco. In 2016, the US Food and Drug Administration determined that electronic cigarettes are subject to their regulation, just like traditional tobacco products, and allowed manufacturers to apply for approval before 2020.


Last autumn, these six companies petitioned with the 11th Circuit Court to review the FDA's denial of their applications to market various flavored e-cigarettes and liquids. These were among the over 55,000 such products that the agency rejected last year.


Chief Justice William Pryor and Circuit Judge Andrew Brasher jointly stated that the FDA's reasoning was due to "a federal district court judge refusing to hear arguments from the defendant regarding their reform plans or their impact on their family, because the judge, based on their experience, found these things to be irrelevant.


Circuit judge Robin Rosenbaum, who holds a dissenting opinion, stated that sending the case back to the US Food and Drug Administration would be "futile".


Statement:


This article is compiled from third-party information and is intended for industry exchange and learning purposes only.


This article does not represent the views of 2FIRSTS, and 2FIRSTS is also unable to confirm the authenticity and accuracy of the article's content. The compilation of this article is intended for industry exchange and research purposes only.


Due to limitations in the level of translation, the compiled article may not accurately convey the original meaning. Please refer to the original article for accuracy.


2FIRSTS maintains complete alignment with the Chinese government on any domestic, Hong Kong, Macao, Taiwan, and foreign-related statements and positions.


The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

2Firsts “Decisive 2026” Concludes: Reviewing the 2025 U.S. Market and Mapping Compliance Pathways Ahead
2Firsts “Decisive 2026” Concludes: Reviewing the 2025 U.S. Market and Mapping Compliance Pathways Ahead
2Firsts hosted “Decisive 2026” in Shenzhen, bringing together industry perspectives to examine major shifts in the U.S. new tobacco market in 2025 and their global implications. Sessions covered U.S. market dynamics, technical insights from recently PMTA-authorized products, an investor lens on tobacco capital markets, and 2025 news/product highlights. The event underscored a structural shift from “gray business” toward compliance and sustainable growth, expected to become clearer by 2026.
Jan.09
Singapore detected 59 large-scale vape smuggling cases in 2025, seizing about 230,000 items
Singapore detected 59 large-scale vape smuggling cases in 2025, seizing about 230,000 items
Singapore’s Ministry of Health said on Feb. 3 that authorities detected 59 large-scale vape smuggling cases in 2025 and seized about 230,000 vapes and accessories. Over the past two years, more than 10,000 online vape sale advertisements were removed, with about 99% linked to overseas platform posts. Enforcement includes bot-driven surveillance, public tip-offs, and site-blocking with partner agencies.
Feb.04 by 2FIRSTS.ai
Federal Register notice: FDA seeks comments on “Warning Plans for Certain Tobacco Products”
Federal Register notice: FDA seeks comments on “Warning Plans for Certain Tobacco Products”
The U.S. Food and Drug Administration (FDA) issued a notice stating it has submitted a proposed information collection to the Office of Management and Budget (OMB) for review under the Paperwork Reduction Act.
Jan.16 by 2FIRSTS.ai
The UK government plans to expand the scope of its e-cigarette ban to include playgrounds, off-campus areas, and areas outside hospitals.
The UK government plans to expand the scope of its e-cigarette ban to include playgrounds, off-campus areas, and areas outside hospitals.
Government plans would ban vaping in cars carrying children and restrict smoking, vaping and heated tobacco in settings including playgrounds and outside schools across England, subject to a 12-week public consultation. The proposals also say indoor spaces where smoking is already banned would become vape- and heated-tobacco-free, and areas outside hospitals would be included.
Feb.13 by 2FIRSTS.ai
Oregon Senate Passes Bill to Regulate Nicotine Pouches as Tobacco Products
Oregon Senate Passes Bill to Regulate Nicotine Pouches as Tobacco Products
The Oregon Senate voted 26–1 to pass Senate Bill 1571, a measure redefining tobacco products to include nicotine pouches and restricting their sale to individuals under 21.
Regulations
Feb.23
Malaysia’s vape industry flags “policy U-turn” concerns after ban on refillable open-system e-cigarettes
Malaysia’s vape industry flags “policy U-turn” concerns after ban on refillable open-system e-cigarettes
Malaysia’s vape industry has raised concerns over the government’s decision to ban refillable open-system e-cigarettes, describing it as a policy reversal despite earlier regulatory approvals.
Jan.08 by 2FIRSTS.ai